Enoxaparin Sodium Injection
Product Images NDC 0548-5602

Product Visual Gallery

This gallery contains 40 technical images submitted to the FDA as part of the official labeling for Enoxaparin Sodium (NDC 0548-5602). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amphastar Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Instruction1 (Enoxaparin 00)

Illustration showing proper and improper handling of a prefilled syringe containing Enoxaparin Sodium injection. The left panel demonstrates correct use with a hand holding the syringe properly, while the right panel indicates an incorrect method with a crossed-out symbol over the image.*

FDA Label Image

Instruction2 (Enoxaparin 01)

Illustration showing hands handling a syringe filled with a liquid medication, indicating a step in preparing or administering an injection with directional arrows pointing left and right along the syringe barrel.*

FDA Label Image

Instruction3 (Enoxaparin 02)

An instructional diagram showing a hand holding a syringe with labeled components including a safety device and activation prongs. The image emphasizes not touching the safety device activation prongs, likely illustrating part of the correct handling or administration procedure for an injection product.*

FDA Label Image

Instruction4 (Enoxaparin 03)

An instructional illustration depicting a close-up of hands preparing a syringe for injection, showing the process of removing or handling the syringe cap or needle cover. No additional text or labeling is visible.*

FDA Label Image

Instruction5 (Enoxaparin 04)

An instructional illustration showing a hand holding a syringe, preparing to administer a subcutaneous injection. The image emphasizes the correct angle and technique for injection, relevant to the use of Enoxaparin Sodium injection by Amphastar Pharmaceuticals, Inc.*

FDA Label Image

Instruction6 (Enoxaparin 05)

An instructional diagram showing a hand holding a syringe and a vial in a preparation or injection process, likely related to the administration of Enoxaparin sodium injection. The image demonstrates proper handling technique for subcutaneous injection.*

FDA Label Image

Chemical Structure (Enoxaparin 06)

Chemical structure of Enoxaparin sodium, showing its polysaccharide chain with repeating units including sodium carboxylate groups, hydroxyl groups, and amino substituents.*

FDA Label Image

Chemical Structure (Enoxaparin 07)

Chemical structure of enoxaparin sodium, showing the molecular connectivity and arrangement of atoms specific to the active ingredient.*

FDA Label Image

Figure1 (Enoxaparin 08)

A forest plot chart depicting relative risk comparisons between Unfractionated Heparin (UFH) and Enoxaparin (Enox) across multiple patient subgroups. The x-axis represents relative risk with markers showing Enoxaparin's effect better on the left and UFH better on the right. Patient subgroups include sex, age, infarct location, diabetes status, prior myocardial infarction, fibrinolytic agent use, time to treatment, and PCI status within 30 days. Data columns include number of patients, UFH percentage, Enox percentage, and risk reduction percentages.*

FDA Label Image

Figure2 (Enoxaparin 09)

A Kaplan-Meier survival curve chart comparing the hazard of death or myocardial re-infarction over 30 days between Enoxaparin and UFH (unfractionated heparin). The chart includes data series labeled 'Enoxaparin' and 'UFH' with corresponding hazard rates on the vertical axis and time in days on the horizontal axis. The chart also contains an inset showing a similar comparison over a 1-year period, along with log-rank test p-values indicating statistical significance.*

FDA Label Image

Figure1 (Ifu Figure1)

An instructional diagram showing two views of a syringe labeled with parts: "Plunger Rod," "Needle," and "Needle Cover." The "Before Use" diagram shows the needle cover in place, while the "After Use" diagram shows the needle covered by a protective sleeve after retraction of the plunger rod. This likely illustrates safe handling or disposal of the syringe after use.*

FDA Label Image

Figurea (Ifu Figurea)

An instructional illustration showing contents of an Enoxaparin Sodium Injection kit. The labeled components include one syringe containing Enoxaparin Sodium Injection, a sharps disposal container, one cotton ball or gauze, one alcohol wipe, and one small adhesive bandage.*

FDA Label Image

Figureb (Ifu Figureb)

An instructional line drawing showing a hand holding a prefilled syringe, likely representing the administration or handling of Enoxaparin Sodium injection. The syringe is positioned in a molded tray, illustrating proper grip and orientation for use.*

FDA Label Image

Figurec (Ifu Figurec)

An instructional line drawing showing a syringe labeled with an expiration date indicator. The syringe includes a plunger, barrel, and needle, consistent with administration via injection.*

FDA Label Image

Figured (Ifu Figured)

An illustration showing a syringe filled with a clear liquid, labeled "Clear Liquid." This image likely represents the injectable form of Enoxaparin Sodium used for subcutaneous administration.*

FDA Label Image

Figuree (Ifu Figuree)

An illustration showing a human torso from the front, highlighting two gray rectangular areas on the lower abdomen, likely indicating preferred injection sites for subcutaneous administration.*

FDA Label Image

Figuref (Ifu Figuref)

An instructional illustration showing a hand holding a small square pad and pressing it against the skin of a person's abdomen above the waistband, demonstrating a step in subcutaneous injection site care or preparation.*

FDA Label Image

Figureg (Ifu Figureg)

An instructional illustration showing hands holding a prefilled syringe labeled Enoxaparin Sodium injection. The image demonstrates how to remove the needle cap by pulling it straight off, indicated by arrows pointing left and right. The syringe syringe includes a plunger and a needle at one end.*

FDA Label Image

Figureh (Ifu Figureh)

An instructional diagram showing a hand holding a syringe with a dose setting mechanism. An arrow points downward indicating the direction to set the dose, accompanied by text that reads "Set your dose." This image is likely related to dosage adjustment for an injection product, such as Enoxaparin Sodium subcutaneous injection.*

FDA Label Image

Figurei (Ifu Figurei)

An instructional diagram showing a hand administering a subcutaneous injection in the abdominal area, illustrating proper injection technique consistent with Enoxaparin sodium injection use.*

FDA Label Image

Figurej (Ifu Figurej)

An instructional diagram showing the proper technique for administering a subcutaneous injection at a 90-degree angle. It depicts a hand holding a syringe inserted perpendicularly into the skin of an abdominal area, with an arrow indicating the direction and positioning of the injection.*

FDA Label Image

Figurek (Ifu Figurek)

An instructional illustration showing a person self-administering an injection by injecting Enoxaparin Sodium subcutaneously into the abdominal area. The image depicts proper hand positioning with one hand holding the syringe and the other slightly pinching the skin, with an arrow indicating the injection direction.*

FDA Label Image

Figurel (Ifu Figurel)

An instructional illustration showing a person pinching the skin of the lower abdomen and preparing to inject medication with a syringe, indicating a subcutaneous injection technique.*

FDA Label Image

Figurem (Ifu Figurem)

An instructional illustration showing a hand holding a syringe labeled with a "Protective Sleeve." An arrow points left, indicating the direction to remove or slide the protective sleeve from the syringe. The image likely demonstrates part of the preparation or safety steps for a subcutaneous injection of Enoxaparin Sodium.*

FDA Label Image

Figuren (Ifu Figuren)

An instructional diagram showing a hand disposing of an Enoxaparin Sodium injection syringe by placing it needle-first into a labeled sharps disposal container. The syringe and its needle cover are clearly identified, emphasizing safe disposal practices.*

FDA Label Image

Carton Stock No.: 5601 (principal Panel) (Carton 5601a)

Packaging label for Enoxaparin Sodium Injection, 30 mg/0.3 mL strength, from Amphastar Pharmaceuticals, Inc. The label indicates the product is for subcutaneous use and comes as a single dose syringe with an automatic safety device. It includes regulatory information such as the NDC 0548-5601-00 and states Rx only.*

FDA Label Image

Carton Stock No.: 5601 (Carton 5601b)

Packaging label for Enoxaparin Sodium Injection 30 mg/0.3 mL by Amphastar Pharmaceuticals, Inc. The label indicates ten 0.3 mL single-dose syringes for subcutaneous use, each containing 30 mg enoxaparin sodium. It includes usage instructions, storage conditions, and regulatory information. The label features a blue and white design with barcode and lot/expiration placeholders.*

FDA Label Image

Carton Stock No.: 5602 (principal Panel) (Carton 5602a)

Packaging label for Enoxaparin Sodium Injection 40 mg/0.4 mL by Amphastar Pharmaceuticals, Inc. The label indicates the product is for subcutaneous use and available as ten 0.4 mL single-dose syringes with an automatic safety device. The label includes the NDC 0548-5650-20 and instructs users to call a doctor for medical advice about side effects.*

FDA Label Image

Carton Stock No.: 5602 (Carton 5602b)

Enoxaparin Sodium Injection 40 mg/0.4 mL single dose syringe packaging label by Amphastar Pharmaceuticals, Inc. The label indicates it is for subcutaneous use only, non-Vanish area, with dosing instructions and storage warnings. Includes NDC 0548-5602-00 and bar code.*

FDA Label Image

Carton Stock No.: 5603 (principal Panel) (Carton 5603a)

Box packaging label for Enoxaparin Sodium Injection 60 mg/0.6 mL, a subcutaneous injection by Amphastar Pharmaceuticals, Inc. The label highlights single-dose syringes with an automatic safety device and includes the NDC 0548-5603-00. It notes Rx only and provides a contact number for reporting side effects.*

FDA Label Image

Carton Stock No.: 5603 (Carton 5603b)

Box packaging label for Enoxaparin Sodium Injection containing 60 mg/0.6 mL single dose syringes. The label indicates the product is for subcutaneous use and non-vaccine, with directions for single use and automatic safety devices. The labeler is Amphastar Pharmaceuticals, Inc. The box includes storage instructions and a warning to keep out of reach of children.*

FDA Label Image

Carton Stock No.: 5604 (principal Panel) (Carton 5604a)

Packaging label for Enoxaparin Sodium Injection 80 mg/0.8 mL by Amphastar Pharmaceuticals, Inc. The label indicates the product is for subcutaneous use only, supplied as ten 0.8 mL single dose syringes with an automatic safety device. The NDC code 0548-5604-00 is visible, and the label includes regulatory and contact information.*

FDA Label Image

Carton Stock No.: 5604 (Carton 5604b)

Packaging label for Enoxaparin Sodium Injection 80 mg/0.8 mL by Amphastar Pharmaceuticals, Inc. The label indicates single dose syringes for subcutaneous use, containing 80 mg enoxaparin sodium per 0.8 mL. The product is non-Vanish area and Rx only with ten 0.8 mL single dose syringes including an automatic safety device.*

FDA Label Image

Carton Stock No.: 5605 (principal Panel) (Carton 5605a)

Packaging label for Enoxaparin Sodium Injection 100 mg/mL by Amphastar Pharmaceuticals, Inc. The label indicates the product is for subcutaneous use and sold as single-dose syringes with an automatic safety device. It includes usage instructions and contact information for adverse effect reporting, along with NDC 0548-5605-00.*

FDA Label Image

Carton Stock No.: 5605 (Carton 5605b)

Packaging label for Enoxaparin Sodium Injection 100 mg/mL, a subcutaneous injection by Amphastar Pharmaceuticals, Inc. The carton indicates it contains ten 1 mL single-dose syringes with an automatic safety device. The label states it is for prescription use only with instructions to see the user guide and product website for more details.*

FDA Label Image

Carton Stock No.: 5606 (principal Panel) (Carton 5606a)

Packaging label for Enoxaparin Sodium Injection 120 mg/0.8 mL by Amphastar Pharmaceuticals, Inc. The label indicates it is a single-dose injection for subcutaneous use, with ten 0.8 mL single-dose syringes containing an automatic safety device. The label includes NDC 0548-5606-00 and is marked Rx only.*

FDA Label Image

Carton Stock No.: 5606 (Carton 5606b)

Enoxaparin Sodium Injection 120 mg/0.8 mL in single-dose syringes by Amphastar Pharmaceuticals, Inc. The label indicates non-Vanrish area, subcutaneous administration, and packaging contains ten 0.8 mL syringes with autoinject safety devices. Storage instructions and warnings about child safety are included. NDC 0548-5606-00 is displayed.*

FDA Label Image

Carton Stock No.: 5607 (principal Panel) (Carton 5607a)

Packaging label for Enoxaparin Sodium Injection 150 mg/mL by Amphastar Pharmaceuticals, Inc. The label indicates it is an Rx-only, subcutaneous injection. It includes instructions for use with autoreflex safety devices and a call to report side effects to the FDA. The label displays NDC 0548-5607-00 and manufacturing details.*

FDA Label Image

Carton Stock No.: 5607 (Carton 5607b)

Packaging label for Enoxaparin Sodium Injection 150 mg/mL by Amphastar Pharmaceuticals, Inc. The label indicates a 1 mL single dose syringe with automatic safety device for subcutaneous use. It includes handling instructions, storage conditions, and dosing information for the injection.*

FDA Label Image

Carton Stock No.: 5608(principal Panel) (Carton 5608)

Packaging label for Enoxaparin Sodium Injection, USP 300 mg/3 mL (100 mg/mL) by Amphastar Pharmaceuticals, Inc. The label indicates it is a prescription injection for subcutaneous or intravenous use, supplied as a multiple dose vial containing 3 mL. It includes dosage, administration, storage instructions, and a warning to keep out of reach of children.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.